ResearcherTyrolean Cancer Research InstituteActive in the last 2 years
Andreas Seeber
Matched on ORCID iD 0000-0001-8529-7824; OpenAlex author ID A5081366644. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational s… Co-author DOI 10.1016/j.esmogo.2024.100042↗
- Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. Last author DOI 10.1158/1078-0432.ccr-22-0275↗
- Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/esmoopen-2020-000942↗
- Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Co-author DOI 10.1111/his.12307↗
- Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. Co-author DOI 10.1245/s10434-012-2381-8↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Heinz‐Josef Lenz · 3 shared papers, 2020–2024 · strength 0.36
- Paper Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinom… DOI 10.1016/j.esmogo.2024.100042↗
- Paper Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clini… DOI 10.1158/1078-0432.ccr-22-0275↗
- Paper Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. DOI 10.1136/esmoopen-2020-000942↗
- Anthony Frank Shields · 3 shared papers, 2020–2024 · strength 0.36
- Paper Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinom… DOI 10.1016/j.esmogo.2024.100042↗
- Paper Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clini… DOI 10.1158/1078-0432.ccr-22-0275↗
- Paper Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. DOI 10.1136/esmoopen-2020-000942↗
- Emil Lou · 2 shared papers, 2022–2024 · strength 0.28
- Paper Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinom… DOI 10.1016/j.esmogo.2024.100042↗
- Paper Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clini… DOI 10.1158/1078-0432.ccr-22-0275↗
- Wafik S. El‐Deiry · 2 shared papers, 2020–2024 · strength 0.26
- Florian Kocher · 2 shared papers, 2020–2022 · strength 0.19
- Alberto Puccini · 2 shared papers, 2020–2022 · strength 0.19
- Richard M. Goldberg · 2 shared papers, 2020–2022 · strength 0.19
- Michael J. Hall · 2 shared papers, 2020–2022 · strength 0.19
- Wolfgang Michael Korn · 2 shared papers, 2020–2022 · strength 0.19
- John Lindsay Marshall · 2 shared papers, 2020–2022 · strength 0.19
- Davendra P. S. Sohal · 1 shared paper, 2024 · strength 0.17
- Sepideh Gholami · 1 shared paper, 2024 · strength 0.17
- Erik B. Faber · 1 shared paper, 2024 · strength 0.17
- Anwaar Saeed · 1 shared paper, 2024 · strength 0.17
- Gregory P. Botta · 1 shared paper, 2024 · strength 0.17
- Gulam Abbas Manji · 1 shared paper, 2024 · strength 0.17
- Gilbert Spizzo · 3 shared papers, 2012–2020 · strength 0.16
- Paper Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma. DOI 10.1136/esmoopen-2020-000942↗
- Paper Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in pa… DOI 10.1111/his.12307↗
- Paper Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. DOI 10.1245/s10434-012-2381-8↗
- Angelica Petrillo · 1 shared paper, 2022 · strength 0.11
- Johannes Haybaeck · 1 shared paper, 2022 · strength 0.11
- Mohamed E. Salem · 1 shared paper, 2022 · strength 0.11
- Axel F. Grothey · 1 shared paper, 2020 · strength 0.09
- Philip A. Philip · 1 shared paper, 2020 · strength 0.09
- Patrizia Lucia Moser · 2 shared papers, 2012–2014 · strength 0.07
- Paper Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in pa… DOI 10.1111/his.12307↗
- Paper Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. DOI 10.1245/s10434-012-2381-8↗
- Dominic Fong · 2 shared papers, 2012–2014 · strength 0.07
- Paper Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in pa… DOI 10.1111/his.12307↗
- Paper Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. DOI 10.1245/s10434-012-2381-8↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.